首页> 外文学位 >Development of a probiotic colicinogenic mix to inhibit Escherichia coli O157:H7 in cattle.
【24h】

Development of a probiotic colicinogenic mix to inhibit Escherichia coli O157:H7 in cattle.

机译:开发一种可抑制牛中大肠杆菌O157:H7的益生菌致癌混合物。

获取原文
获取原文并翻译 | 示例

摘要

A previously identified set of colicinogenic Escherichia coli inhibitory to E. coli O157:H7 was assessed as a pre-harvest food safety intervention in cattle. Twenty-three colicinogenic E. coli were first characterized for virulence factors, antibiotic resistance, and type of colicin(s) present. Nine strains were eliminated from the collection due to possession of a pathogen gene or antibiotic resistance. The remaining fourteen strains were evaluated for previously identified colicins. Seven colicins (B, E1, E2/E7, E7, Ia/Ib, K, and M) were detected. Eight strains that produced colicin E7 were assessed for their ability to inhibit E. coli O157:H7 in artificially inoculated calves. The cattle experiment consisted of three periods that evaluated two probiotic dose levels, with the treatment animals receiving either 107 or 108 CFU/g of colicinogenic E. coli in their feed daily. The count of E. coli O157:H7 was consistently higher during the three periods in the control groups. One group comparison found an overall difference of 1.1 log10 CFU/g reduction that was observed with a maximum decrease of 1.8 log10 CFU/g. The overall statistical significance was P = 0.001. Serotype O157:H7 was detected in 44% of the treatment group's intestinal tissue samples and in 64% of those from the control group (P 0.04). Ninety-six strains of E. coli O157:H7 were assessed for their resistance potential against anti-0157 colicinogenic E. coli. Thirteen of the fourteen anti-O157 colicinogenic E. coli strains were able to inhibit all 96 E. coli O157:H7 strains. Thirteen of 96 E. coli O157:H7 strains were found to be colicinogenic and eleven of those had genes that encoded for colicin D. PCR products for colicins B, E-type, Ia/Ib and M were also detected individually or combined with other colicins in four strains. The ability of colicin resistance development against single-colicin producing E. coli was observed under in vitro conditions, however the ability of E. coli O157:H7 to become colicinogenic or colicin resistant under in vivo conditions was not observed. These findings indicate that colicinogenic E. coli may be used to reduce E. coli O157:H7 fecal shedding in cattle.
机译:先前确定的一组抑制大肠杆菌O157:H7的致癌性大肠杆菌被评估为牛收获前的食品安全干预措施。首先对二十三种致癌大肠埃希氏菌的毒力因子,抗生素抗性和存在的大肠菌素类型进行了表征。由于拥有病原体基因或抗生素抗性,从集合中淘汰了9个菌株。对其余十四个菌株进行了先前鉴定的大肠菌素评估。检测到七个大肠菌素(B,E1,E2 / E7,E7,Ia / Ib,K和M)。评估了产生大肠杆菌素E7的八种菌株在人工接种牛犊中抑制大肠杆菌O157:H7的能力。牛实验由三个时期组成,评估了两个益生菌的剂量水平,治疗动物每天在饲料中接受107或108 CFU / g大肠埃希氏致病性大肠杆菌。在对照组的三个时期中,大肠杆菌O157:H7的计数始终较高。一组比较发现总体下降为1.1 log10 CFU / g,最大下降为1.8 log10 CFU / g。总体统计显着性为P = 0.001。在治疗组的肠组织样本中有44%和对照组的检出率分别为O157:H7血清型(P <0.04)。评估了96种大肠杆菌O157:H7菌株对抗0157致癌性大肠杆菌的抗性。 14种抗O157致癌性大肠杆菌菌株中的13种能够抑制所有96种O157:H7大肠杆菌。发现96株O157:H7大肠杆菌中有13株是致癌性的,其中11株具有编码大肠菌素D的基因。还分别检测到大肠菌素B,E型,Ia / Ib和M的PCR产物大肠菌素四种菌株。在体外条件下观察到了大肠菌素对产生单链霉素的大肠杆菌的抗性发展能力,但是在体内条件下未观察到大肠杆菌O157:H7变成致癌或对大肠菌素具有抗性的能力。这些发现表明,致癌性大肠杆菌可用于减少牛的大肠杆菌O157:H7粪便脱落。

著录项

  • 作者

    Schamberger, Gerry Paul.;

  • 作者单位

    University of Minnesota.;

  • 授予单位 University of Minnesota.;
  • 学科 Agriculture Food Science and Technology.; Biology Animal Physiology.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 148 p.
  • 总页数 148
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 农产品收获、加工及贮藏;生理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号